Skip to main content
Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.46
-0.03 (-0.55%)
Jan 17, 2025, 4:00 PM EST - Market closed

Cytek Biosciences Revenue

Cytek Biosciences had revenue of $51.50M in the quarter ending September 30, 2024, with 7.29% growth. This brings the company's revenue in the last twelve months to $201.21M, up 9.88% year-over-year. In the year 2023, Cytek Biosciences had annual revenue of $193.02M with 17.67% growth.

Revenue (ttm)
$201.21M
Revenue Growth
+9.88%
P/S Ratio
3.57
Revenue / Employee
$297,648
Employees
676
Market Cap
703.31M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023193.02M28.98M17.67%
Dec 31, 2022164.04M36.09M28.20%
Dec 31, 2021127.95M35.11M37.82%
Dec 31, 202092.84M34.96M60.39%
Dec 31, 201957.88M52.27M930.36%
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings

CTKB News

More News